Review article: Genetic testing and counselling for hereditary colorectal cancer

Research output: Contribution to journalArticle

Abstract

Colorectal cancer is the second leading cause of cancer death, after lung cancer, in the USA. The great majority (80%) of patients with colorectal cancer have sporadic disease with no evidence of having inherited the disorder. In the remaining 20%, a potentially definable genetic component exists. With the discovery of gene mutations related to hereditary colorectal cancer, risk assessment based on genetic test results is now feasible. The following review focuses on the two well-described colorectal cancer genetic syndromes - familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer, the process of genetic counselling, currently available genetic tests, and indications for their use.

Original languageEnglish (US)
Pages (from-to)1843-1857
Number of pages15
JournalAlimentary Pharmacology and Therapeutics
Volume16
Issue number11
DOIs
StatePublished - Nov 1 2002

Fingerprint

Genetic Counseling
Genetic Testing
Colorectal Neoplasms
Hereditary Nonpolyposis Colorectal Neoplasms
Adenomatous Polyposis Coli
Genetic Association Studies
Cause of Death
Lung Neoplasms
Mutation
Neoplasms

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

@article{8dda25d628bc4174ada140a1d331fd10,
title = "Review article: Genetic testing and counselling for hereditary colorectal cancer",
abstract = "Colorectal cancer is the second leading cause of cancer death, after lung cancer, in the USA. The great majority (80{\%}) of patients with colorectal cancer have sporadic disease with no evidence of having inherited the disorder. In the remaining 20{\%}, a potentially definable genetic component exists. With the discovery of gene mutations related to hereditary colorectal cancer, risk assessment based on genetic test results is now feasible. The following review focuses on the two well-described colorectal cancer genetic syndromes - familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer, the process of genetic counselling, currently available genetic tests, and indications for their use.",
author = "{Brensinger Trimbath}, Jill and Giardiello, {Francis M}",
year = "2002",
month = "11",
day = "1",
doi = "10.1046/j.1365-2036.2002.01357.x",
language = "English (US)",
volume = "16",
pages = "1843--1857",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Review article

T2 - Genetic testing and counselling for hereditary colorectal cancer

AU - Brensinger Trimbath, Jill

AU - Giardiello, Francis M

PY - 2002/11/1

Y1 - 2002/11/1

N2 - Colorectal cancer is the second leading cause of cancer death, after lung cancer, in the USA. The great majority (80%) of patients with colorectal cancer have sporadic disease with no evidence of having inherited the disorder. In the remaining 20%, a potentially definable genetic component exists. With the discovery of gene mutations related to hereditary colorectal cancer, risk assessment based on genetic test results is now feasible. The following review focuses on the two well-described colorectal cancer genetic syndromes - familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer, the process of genetic counselling, currently available genetic tests, and indications for their use.

AB - Colorectal cancer is the second leading cause of cancer death, after lung cancer, in the USA. The great majority (80%) of patients with colorectal cancer have sporadic disease with no evidence of having inherited the disorder. In the remaining 20%, a potentially definable genetic component exists. With the discovery of gene mutations related to hereditary colorectal cancer, risk assessment based on genetic test results is now feasible. The following review focuses on the two well-described colorectal cancer genetic syndromes - familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer, the process of genetic counselling, currently available genetic tests, and indications for their use.

UR - http://www.scopus.com/inward/record.url?scp=0036828652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036828652&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2036.2002.01357.x

DO - 10.1046/j.1365-2036.2002.01357.x

M3 - Article

C2 - 12390093

AN - SCOPUS:0036828652

VL - 16

SP - 1843

EP - 1857

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - 11

ER -